Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Grows By 19.9%

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 492,300 shares, an increase of 19.9% from the June 30th total of 410,600 shares. Approximately 1.6% of the shares of the stock are short sold. Based on an average trading volume of 54,600 shares, the short-interest ratio is presently 9.0 days.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Oak Family Advisors LLC lifted its stake in shares of Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock worth $728,000 after acquiring an additional 1,208 shares during the last quarter. Activest Wealth Management purchased a new stake in shares of Bioceres Crop Solutions during the first quarter valued at $30,000. Cape Investment Advisory Inc. purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter valued at $33,000. Wellington Management Group LLP increased its stake in Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after buying an additional 7,096 shares during the period. Finally, Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions during the 1st quarter valued at about $139,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Trading Down 0.6 %

NASDAQ BIOX traded down $0.07 on Tuesday, hitting $10.93. 20,026 shares of the stock were exchanged, compared to its average volume of 58,235. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.83 and a current ratio of 1.22. Bioceres Crop Solutions has a 52-week low of $10.10 and a 52-week high of $14.05. The firm has a market capitalization of $686.40 million, a P/E ratio of 1,093.00 and a beta of 0.50. The stock has a fifty day moving average price of $10.99 and a two-hundred day moving average price of $12.16.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Wednesday, May 29th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The firm had revenue of $83.98 million for the quarter, compared to analysts’ expectations of $88.80 million. Research analysts forecast that Bioceres Crop Solutions will post 0.35 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on BIOX shares. Roth Mkm assumed coverage on Bioceres Crop Solutions in a research note on Tuesday, July 2nd. They set a “buy” rating and a $15.00 target price on the stock. Canaccord Genuity Group reissued a “buy” rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Three research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $19.00.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.